Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.
about
Dystrophic epidermolysis bullosa: a reviewRaising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure.Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.A single epidermal stem cell strategy for safe ex vivo gene therapy."...Rewritten in the skin": clues to skin biology and aging from inherited disease.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies.Therapies for inherited skin fragility disorders.Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.Revertant mosaicism in genodermatoses.Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen.A living band-aid for epidermolysis bullosa.Rapid generation of Col7a1-/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells.Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
P2860
Q28084871-5390112E-6C89-40D9-9FF6-BC7424C8D5C2Q33821599-9AA4C3B6-8169-4FA4-BE93-0E8E66DCF934Q33948142-22D86021-97FB-4C84-ABE1-FE9585749C81Q34678948-FDB8B632-AAD2-4F8B-BC70-289FCC3D30F0Q35483739-063C6582-E24C-448A-8C74-D25E25E56617Q35920445-02210C2A-382B-408F-BD45-7456CE067D31Q37522548-486D15CC-B08F-4D28-B6C5-731E72B70B44Q37712686-A2156E3D-9CEC-4149-B79F-E0AD43EEE2C0Q38180485-9D6A6F6D-553B-4EA9-9659-EBD27EA21A54Q38444460-365C5D0A-CF0C-4D93-8413-D1929C296544Q39044711-2C86E58D-6277-4987-84B1-600B22CC685EQ39123627-97AA1EDA-9B10-4663-80C3-4CBCE76707BAQ42504595-A6B0FAF4-834E-483A-80D9-F29CC21200C2Q43131862-34691363-4A41-4B7C-B3F2-CA7C2543F80BQ47690335-A44288D5-A9C8-45AD-888E-5F1C456B5B51Q53770761-488B9882-6D82-4832-A7B8-74D375B9BA37Q57159704-EF2D4878-2B5F-4AA9-A474-630286BD9991
P2860
Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@en
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@nl
type
label
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@en
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@nl
prefLabel
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@en
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@nl
P2860
P1433
P1476
Allogeneic blood and bone marr ...... r of the extracellular matrix.
@en
P2093
John E Wagner
P2860
P304
P356
10.1016/S0140-6736(13)61897-8
P407
P50
P577
2013-10-01T00:00:00Z